hvsa
Home
Courses
Course Objectives
Programs
CME Credits
Cases and Abstract Submissions
venue and accomodations
HVSA
Directors and Faculty
Videos
Register

 

New York City Conference

Back to 2014 Annual Meeting Abstracts


Beating Heart Valve Surgery Post Myocardial Revascularization With Patent Grafts
Paolo Pepino, MD, Salvatore Giordano, MD, Piermario Oliviero, MD, Germano Coronella, MD, Raffaela Provenzano, MD, Giuseppe Pescatore, MD, Antonio Contaldo, MD, Antonella Luciano, MD, Mario Monaco, MD.
Presidio Ospedaliero Pineta Grande, Castel Volturno, Caserta, Italy.

OBJECTIVE: Valve surgery in patients with previous CABG and patent arterials conducts is a challenging procedure. To avoid any risk of injury the grafts, we performed valve surgery with the beating heart: 4 aortic valve replacement (AVR); 1 ascending aorta replacement and 2 mitral valve replacement (MVR). METHODS: From September 2010 up to May 2013 seven patients (four male and three female, aged 67,66±10,85, pre op LVEF 47,85±6,46) with a story of previous CABG (three patients using left internal mammary artery + saphenous vein; four patients using LIMA + radial artery; one patient using also the right internal mammary artery, number of by pass 2.85±0.63) were admitted in our department for valvular or ascending aorta disease. All patients had previous coronarography with patent arterial conduit in six patients, while in one patient an occluded LIMA graft on the LAD and a patent radial artery graft from the LIMA on the first and second obtuse marginal were observed. Reoperations were performed on beating heart. Arterial conducts were not isolated to avoid possible injury and the procedures were performed cross- clamping the aorta, on pump, perfusing the coronary trough the patents graft and with a retrograde perfusion with a cannula in the coronary sinus. RESULTS: The aortic cross clamp time was 81,8±20,1. Two patients had AVR with biological valve, two patients had AVR with mechanical valve, one patient had replacement of the ascending aorta with a dacron graft and two patients had MVR with biologic valve. No major complications were observed. No in hospital mortality was observed and all patients were discharged in 6,5±0,9 days post op, showing a LVEF of 49,28±5,62. CONCLUSION: Beating heart surgery is a safe procedure in patients who received a previous CABG. Maintaining coronary perfusion through the patents arterial conducts and through the retrograde perfusion will protect the heart without any ischemia.


Back to 2014 Annual Meeting Abstracts

     

Home | Courses | Objectives | Program | CME Credit | Cases & Abstracts | Venu & Accomodations | HVSA | Committee & Faculty | Register | Privacy Policy